• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效液相色谱法同时测定非索非那定及其有关物质

Simultaneous determination of fexofenadine and its related compounds by HPLC.

作者信息

Radhakrishna T, Om Reddy G

机构信息

Department of Analytical Research, Dr. Reddy's Research Foundation, Miyapur, 500 050, Hyderabad, India.

出版信息

J Pharm Biomed Anal. 2002 Jul 20;29(4):681-90. doi: 10.1016/s0731-7085(02)00181-4.

DOI:10.1016/s0731-7085(02)00181-4
PMID:12093497
Abstract

A simple reversed phase liquid chromatographic (RPLC) method has been developed and subsequently validated for the determination of fexofenadine hydrochloride and its related compounds A and B. The method utilizes a C8 column for the separation and determination of meta-isomer (related compound B). The separation was achieved using an Eclipse XDB C8, 5 microm, 4.6 x 150 mm column and a mobile phase comprising 1% triethylamine phosphate (pH 3.7), acetonitrile and methanol in the ratio 60:20:20 (v/v/v). 5-Methyl 2-nitrophenol has been used as internal standard for the purpose of quantitation of fexofenadine. The described method was linear over a range of 0.7-18.7 microg/ml for related compounds A and B and 60-750 microg/ml for assay of fexofenadine. The relative standard deviation (n=3) was 0.5% for the drug and 3.4% for related compounds. The intermediate precision was 0.79% (n=9) for assay and 5.16% (n=9) for related impurities. The mean recovery of both the related compounds were in the range of 94-103%. Limits of detection (LOD) and quantification (LOQ) for the related compounds A and B were 0.18, 0.12 and 0.56, 0.48 microg/ml, respectively. The precision of the method was checked by F-test using a reported method as reference and the calculated value (1.35) was found to be less than the table value at 95% confidence levels. The obtained results confirm that the method is highly suitable for its intended purpose.

摘要

已开发出一种简单的反相液相色谱(RPLC)方法,并随后对其进行了验证,用于测定盐酸非索非那定及其相关化合物A和B。该方法使用C8柱分离并测定间位异构体(相关化合物B)。分离采用Eclipse XDB C8,5微米,4.6×150毫米柱,流动相由1%磷酸三乙胺(pH 3.7)、乙腈和甲醇按60:20:20(v/v/v)的比例组成。5-甲基-2-硝基苯酚用作内标,用于定量非索非那定。所描述的方法在0.7 - 18.7微克/毫升范围内对相关化合物A和B呈线性,在60 - 750微克/毫升范围内对非索非那定的含量测定呈线性。该药物的相对标准偏差(n = 3)为0.5%,相关化合物的相对标准偏差为3.4%。含量测定的中间精密度为0.79%(n = 9),相关杂质的中间精密度为5.16%(n = 9)。两种相关化合物的平均回收率在94 - 103%范围内。相关化合物A和B的检测限(LOD)和定量限(LOQ)分别为0.18、0.12和0.56、0.48微克/毫升。使用一种报道的方法作为参考,通过F检验检查了该方法的精密度,发现在95%置信水平下计算值(1.35)小于表值。所得结果证实该方法非常适合其预期用途。

相似文献

1
Simultaneous determination of fexofenadine and its related compounds by HPLC.高效液相色谱法同时测定非索非那定及其有关物质
J Pharm Biomed Anal. 2002 Jul 20;29(4):681-90. doi: 10.1016/s0731-7085(02)00181-4.
2
Development and validation of a liquid chromatographic method for fexofenadine hydrochloride in capsules.
J AOAC Int. 2004 Sep-Oct;87(5):1093-7.
3
Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms.用于二元药物剂型中测定西替利嗪或非索非那定与伪麻黄碱的快速反相高效液相色谱法的开发与验证。
J Pharm Biomed Anal. 2008 Jan 22;46(2):295-302. doi: 10.1016/j.jpba.2007.10.018. Epub 2007 Oct 22.
4
Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies.片剂中盐酸非索非那定的简单可靠的高效液相色谱分析及其在溶出度研究中的应用。
Pharmazie. 2007 Feb;62(2):96-100.
5
Capillary electrophoresis method for fexofenadine hydrochloride in capsules.
J AOAC Int. 2005 Jul-Aug;88(4):1059-63.
6
IDENTIFICATION AND DETERMINATION OF RUPATADINE AND FEXOFENADINE BY DENSITOMETRIC METHOD.
Acta Pol Pharm. 2016 Nov;73(6):1467-1474.
7
Determination of cetirizine dihydrochloride, related impurities and preservatives in oral solution and tablet dosage forms using HPLC.采用高效液相色谱法测定口服溶液剂和片剂剂型中盐酸西替利嗪、相关杂质及防腐剂的含量。
J Pharm Biomed Anal. 2004 Oct 29;36(2):341-50. doi: 10.1016/j.jpba.2004.07.002.
8
Simultaneous determination of gliquidone, fexofenadine, buclizine, and levocetirizine in dosage formulation and human serum by RP-HPLC.采用反相高效液相色谱法同时测定制剂和人血清中的格列喹酮、非索非那定、布克利嗪和左西替利嗪。
J Chromatogr Sci. 2010 May-Jun;48(5):382-5. doi: 10.1093/chromsci/48.5.382.
9
Development of validated stability-indicating chromatographic method for the determination of fexofenadine hydrochloride and its related impurities in pharmaceutical tablets.用于测定药片中盐酸非索非那定及其相关杂质的经验证的稳定性指示色谱方法的开发。
Chem Cent J. 2011 Dec 3;5(1):76. doi: 10.1186/1752-153X-5-76.
10
Determination of fexofenadine in human plasma and urine by liquid chromatography-mass spectrometry.采用液相色谱-质谱联用技术测定人血浆和尿液中的非索非那定。
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jan 25;766(2):227-33. doi: 10.1016/s0378-4347(01)00468-6.

引用本文的文献

1
Development of N,P-doped carbon quantum dots as a green fluorescent probe for fexofenadine determination: mechanistic studies, Box-Behnken optimization, and pharmacokinetic application.氮、磷掺杂碳量子点作为非索非那定测定的绿色荧光探针的开发:机理研究、Box-Behnken优化及药代动力学应用
RSC Adv. 2025 May 6;15(18):14545-14557. doi: 10.1039/d5ra01920f. eCollection 2025 Apr 28.
2
Stability-indicating HPLC Method for Simultaneous Determination of Montelukast and Fexofenadine Hydrochloride.同时测定孟鲁司特和盐酸非索非那定的稳定性指示高效液相色谱法
Indian J Pharm Sci. 2013 May;75(3):284-90. doi: 10.4103/0250-474X.117426.
3
Identification and Characterization of an Oxidative Degradation Product of Fexofenadine, Development and Validation of a Stability-Indicating RP-UPLC Method for the Estimation of Process Related Impurities and Degradation Products of Fexofenadine in Pharmaceutical Formulations.
非索非那定氧化降解产物的鉴定与表征、用于测定药物制剂中非索非那定工艺相关杂质和降解产物的稳定性指示反相超高效液相色谱法的开发与验证
Sci Pharm. 2012 Apr-Jun;80(2):295-309. doi: 10.3797/scipharm.1111-07. Epub 2012 Jan 21.
4
Development of validated stability-indicating chromatographic method for the determination of fexofenadine hydrochloride and its related impurities in pharmaceutical tablets.用于测定药片中盐酸非索非那定及其相关杂质的经验证的稳定性指示色谱方法的开发。
Chem Cent J. 2011 Dec 3;5(1):76. doi: 10.1186/1752-153X-5-76.
5
Validated spectroflurimetric determination of some H1 receptor antagonist drugs in pharmaceutical preparations through charge transfer complexation.经电荷转移络合作用验证的药物制剂中一些 H1 受体拮抗剂药物的分光荧光测定法。
J Fluoresc. 2012 Jan;22(1):175-91. doi: 10.1007/s10895-011-0944-x. Epub 2011 Aug 10.